What is the Growth Outlook for Transplant Diagnostics Market?
The growth of this market is mainly driven by increasing
transplant procedures, technological advancements in transplant diagnostics,
increasing public and private funding for targeted research activities, and
increasing burden on infectious diseases driving the growth of the transplant
diagnostics market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061
The transplant diagnostics market is expected to reach USD
5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.
Based on product, the reagents & consumables segment
held the largest share of the market
On the basis of product, the transplant diagnostics market
is segmented into reagents & consumables, instruments, and software &
services. The reagents & consumables segment held the largest share of the
global transplant diagnostics market
Based on technology, the molecular assays segment is
expected to witness the highest growth during the forecast period.
On the basis of technology, the transplant diagnostics
market is segmented into molecular assay and non-molecular assay technology.
The molecular assay technology segment is expected to register the highest CAGR
during the forecast period.
Based on the transplant type, the solid organ
transplantation segment accounted for the largest share of this market.
On the basis of transplant type, the transplant diagnostics
market is categorized into solid organ, stem cell, and soft tissue
transplantation. Solid organ transplantation accounted for the largest share of
the transplant diagnostics market
North America accounted for the largest share of the
transplant diagnostics market
North America accounted for the largest share of the
transplant diagnostics market in 2019, followed by Europe. This can primarily
be attributed to the continuous commercialization of innovative transplant
diagnostic products coupled with ongoing advancements in the field of genomics
and proteomics, recent discovery genetic biomarkers & their clinical role
in immunoassay testing, and the increasing prevalence of chronic and
communicable diseases.
Some of the prominent players in the transplant
diagnostics market are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche
Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc.
(US), and bioMérieux S.A. (France). Others are Immucor, Inc. (US), Illumina,
Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company
(US), Hologic (US), and GenDx (Netherlands).
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=2531061
Market Segmentation
This research
report categorizes the transplant diagnostics market into the following
segments and subsegments:
By Technology
- Molecular
Assay Technologies
- PCR-Based
Molecular Assays
- Real-time
PCR
- Sequence-specific
Primer-PCR
- Sequence-specific
Oligonucleotide-PCR
- Other
PCR-based Molecular Assays
- Sequencing-based
Molecular Assays
- Sanger
Sequencing
- Next-generation Sequencing
- Other
Sequencing-based Molecular Assays
- Non-molecular
Assay Technologies
By Product & Service
- Reagents
& Consumables
- Instruments
- Software
& Services
By Transplant Type
- Solid
Organ Transplantation
- Kidney
Transplantation
- Liver
Transplantation
- Heart
Transplantation
- Lung
Transplantation
- Pancreas
Transplantation
- Other
Organ Transplantations
- Stem
Cell Transplantation
- Soft
Tissue Transplantation
- Bone
marrow Transplantation
By Application
- Diagnostic
Applications
- Pre-transplantation
Diagnostics
- Infectious
Disease Testing
- Histocompatibility
Testing
- Blood
Profiling
- Post-transplantation
Diagnostics
- Research
Applications
By End User
- Independent
Reference Laboratories
- Hospitals
& Transplant Centers
- Research
Laboratories & Academic Institutes
By Region
- North
America
- Europe
- Asia
Pacific
- Latin
America
- Middle
East and Africa
Comments
Post a Comment